Table 4.
Post-ESD Bleeding Rates According to the Exact Cessation Period in Multiple Antiplatelet Therapy
| Cessation period, day | Post-ESD bleeding events |
|---|---|
| X0Y0 | 4/16 (25.0) |
| X1Y0 | 2/2 (100) |
| X1Y1 | 1/6 (16.7) |
| X2Y1 | 0/1 (0) |
| X2Y2 | 0/1 (0) |
| X3Y0 | 0/1 (0) |
| X3Y3 | 2/2 (100) |
| X4Y0 | 0/1 (0) |
| X4Y4 | 2/4 (50.0) |
| X5Y0 | 0/1 (0) |
| X5Y5 | 0/4 (0) |
| X6Y0 | 1/2 (50.0) |
| X6Y6 | 1/4 (25.0) |
| X7Y7 | 1/6 (16.7) |
| X0Y0Z0 | 1/3 (33.3) |
Data are presented as number/total number (%).
X indicates the antiplatelet agent that was discontinued first. Y, and Z indicate the antiplatelet agents that were discontinued subsequently or continued. The number followed by characters X, Y, and Z indicates the cessation period in days.
ESD, endoscopic submucosal dissection.